Platelet Rich Fibrin And Its Usage In Dental Practic

Year 2012, Volume: 2012 Issue: 3, 325 - 333, 01.03.2012

Dt. Yasemin Sezgin Prof. Dr. İ. Levent Taner

Abstract

-

Keywords

-

Trombositten Zengin Fibrin Ve Dental Uygulamalarda Kullanımı

Abstract

Kan kaynaklı ürünlerin yara yüzeylerinin örtülmesi ve iyileşmenin uyarılması amacıyla kullanımı yaklaşık 40 yıl öncesine dayanmaktadır. İkinci jenerasyon trombosit konsantresi olan Trombositten Zengin Fibrin kanın hiçbir biyokimtasal modifikasyona uğramaksızın santrifüj edilmesine dayanan basit bir tekniğe sahiptir. Bu derlemenin amacı Trombositten Zengin Fibrinin hazırlama tekniği, diğer trombosit konsantrelerinden farkları, biyokimyasal özellikleri hakkında bilgi vermek ve trombositten zengin fibrinin diş hekimliğindeki kullanımı ile ilgili yapılmış çalışmaları gözden geçirmektir

Keywords

trombositten zengin fibrin, büyüme faktörleri, periodontal cerrahi

References

• Marx RE, Garg, A.K. . Dental and craniofacial applications of platelet-rich plasma. Quintessence Publishing 2005:3-30.
• Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol 2009;27:158-167.
• Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR. Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;85:638-646.
• Sanchez AR, Sheridan PJ, Kupp LI. Is platelet-rich plasma the perfect enhancement factor? A current review. Int J Oral Maxillofac Implants 2003;18:93- 103.
• Schmitz JP, Hollinger JO. The biology of platelet- rich plasma. J Oral Maxillofac Surg 2001;59:1119- 1121.
• Lütfüoğlu M. Periodontal Rejenerasyon ve Büyüme Faktörleri. Atatürk Üniv. Di Hek. Fak. Derg. 2007;17:35-43
• Martinez-Gonzalez JM, Cano-Sanchez J, Gonzalo- Lafuente JC, Campo-Trapero J, Esparza-Gomez G, Seoane J. Do ambulatory-use Platelet-Rich Plasma (PRP) concentrates present risks? Med Oral 2002;7:375-390.
• Aukhil I. Biology of wound healing. Periodontol 2000 2000;22:44-50.
• Fujita T, Shiba H, Van Dyke TE, Kurihara H. Differential effects of growth factors and cytokines on the synthesis of SPARC, DNA, fibronectin and alkaline phosphatase activity in human periodontal ligament cells. Cell Biol Int 2004;28:281-286.
• Canalis E, Pash J, Gabbitas B, Rydziel S, Varghese S. Growth factors regulate the synthesis of insulin- like growth factor-I in bone cell cultures. Endocrinology 1993;133:33-38.
• Baylink DJ, Finkelman RD, Mohan S. Growth factors to stimulate bone formation. J Bone Miner Res 1993;8 Suppl 2:S565-572.
• Dereka XE, Markopoulou CE, Vrotsos IA. Role of growth factors on periodontal repair. Growth Factors 2006;24:260-267.
• Matras H. [Effect of various fibrin preparations on reimplantations in the rat skin]. Osterr Z Stomatol 1970;67:338-359.
• Gibble JW, Ness PM. Fibrin glue: the perfect operative sealant? Transfusion 1990;30:741-747.
• Whitman DH, Berry RL, Green DM. Platelet gel: an autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Maxillofac Surg 1997;55:1294-1299.
• Dohan DM, Choukroun J, Diss Aet al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part I: technological concepts and evolution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101:e37-44.
• Dohan DM, Choukroun J, Diss Aet al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part II: platelet-related biologic features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101:e45-50.
• Dohan Ehrenfest DM. How to optimize the preparation of leukocyte- and platelet-rich fibrin (L-PRF, Choukroun's technique) clots and membranes: introducing the PRF Box. Oral Surg Oral Med Oral Pathol Oral Radiol Endod;110:275- 278; author reply 278-280.
• Dohan DM, Choukroun J, Diss Aet al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part III: leucocyte activation: a new feature for platelet concentrates? Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101:e51- 55.
• Mosesson MW, Siebenlist KR, Meh DA. The structure and biological features of fibrinogen and fibrin. Ann N Y Acad Sci 2001;936:11-30.
• Dohan Ehrenfest DM, Del Corso M, Diss A, Mouhyi J, Charrier JB. Three-dimensional architecture and cell composition of a Choukroun's platelet-rich fibrin clot and membrane. J Periodontol;81:546- 555.
• Choukroun J, Diss A, Simonpieri Aet al. Platelet- rich fibrin (PRF): a second-generation platelet concentrate. Part IV: clinical effects on tissue healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101:e56-60.
• Dohan Ehrenfest DM, de Peppo GM, Doglioli P, Sammartino G. Slow release of growth factors and thrombospondin-1 in Choukroun's platelet-rich fibrin (PRF): a gold standard to achieve for all surgical platelet concentrates technologies. Growth Factors 2009;27:63-69.
• He L, Lin Y, Hu X, Zhang Y, Wu H. A comparative study of platelet-rich fibrin (PRF) and platelet-rich plasma (PRP) on the effect of proliferation and differentiation of rat osteoblasts in vitro. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009;108:707-713.
• Dohan Ehrenfest DM, Diss A, Odin G, Doglioli P, Hippolyte MP, Charrier JB. In vitro effects of Choukroun's PRF (platelet-rich fibrin) on human gingival fibroblasts, dermal prekeratinocytes, preadipocytes, and maxillofacial osteoblasts in primary cultures. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009;108:341-352.
• Dohan Ehrenfest DM, Doglioli P, de Peppo GM, Del Corso M, Charrier JB. Choukroun's platelet-rich fibrin (PRF) stimulates in vitro proliferation and differentiation of human oral bone mesenchymal stem cell in a dose-dependent way. Arch Oral Biol;55:185-194.
• Chang IC, Tsai CH, Chang YC. Platelet-rich fibrin modulates the expression of extracellular signal- regulated protein kinase and osteoprotegerin in human osteoblasts. J Biomed Mater Res A;95:327- 332.
• Huang FM, Yang SF, Zhao JH, Chang YC. Platelet- rich fibrin increases proliferation and differentiation of human dental pulp cells. J Endod;36:1628-1632.
• Lee EH, Kim JY, Kweon HYet al. A combination graft of low-molecular-weight silk fibroin with Choukroun platelet-rich fibrin for rabbit calvarial defect. Oral Surg Oral Med Oral Pathol Oral Radiol Endod;109:e33-38.
• Jang ES, Park JW, Kweon Het al. Restoration of peri-implant defects in immediate implant installations by Choukroun platelet-rich fibrin and silk fibroin powder combination graft. Oral Surg Oral Med Oral Pathol Oral Radiol Endod;109:831- 836.
• Kim BJ, Kwon TK, Baek HSet al. A comparative study of the effectiveness of sinus bone grafting with recombinant human bone morphogenetic protein 2-coated tricalcium phosphate and platelet- rich fibrin-mixed tricalcium phosphate in rabbits. Oral Surg Oral Med Oral Pathol Oral Radiol Endod.
• Choukroun J, Diss A, Simonpieri Aet al. Platelet- rich fibrin (PRF): a second-generation platelet concentrate. Part V: histologic evaluations of PRF effects on bone allograft maturation in sinus lift. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101:299-303.
• Zhang Y, Tangl S, Huber CD, Lin Y, Qiu L, Rausch- Fan X. Effects of Choukroun's platelet-rich fibrin on bone deproteinized bovine bone mineral in maxillary in combination with sinus histomorphometric study. J Craniomaxillofac Surg. A histological and
• Summers RB. The osteotome technique: Part 3-- Less invasive methods of elevating the sinus floor. Compendium 1994;15:698, 700, 702-694 passim; quiz 710.
• Diss A, Dohan DM, Mouhyi J, Mahler P. Osteotome sinus floor elevation using Choukroun's platelet- rich fibrin as grafting material: a 1-year prospective pilot study with microthreaded implants. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;105:572-579.
• Mazor Z, Horowitz RA, Del Corso M, Prasad HS, Rohrer MD, Dohan Ehrenfest DM. Sinus floor augmentation placement using Choukroun's platelet-rich fibrin as the sole grafting material: a radiologic and histologic study at 6 months. J Periodontol 2009;80:2056-2064. simultaneous implant
• Toffler M, Toscano N, Holtzclaw D. Osteotome- mediated sinus floor elevation using only platelet- rich fibrin: an early report on 110 patients. Implant Dent;19:447-456.
• Simonpieri A, Choukroun J, Del Corso M, Sammartino G, Dohan Ehrenfest DM. Simultaneous sinus-lift and implantation using microthreaded implants and leukocyte- and platelet-rich fibrin as sole grafting material: a six-year experience. Implant Dent;20:2-12.
• Sharma A, Pradeep AR. Autologous Platelet-Rich Fibrin in the Treatment of Mandibular Degree II Furcation Defects: A Randomized Clinical Trial. J Periodontol;82:1396-1403.
• Wallace SS, Froum SJ. Effect of maxillary sinus augmentation on the survival of endosseous dental implants. A systematic review. Ann Periodontol 2003;8:328-343.
• Raghoebar GM, Timmenga NM, Reintsema H, Stegenga B, Vissink A. Maxillary bone grafting for insertion of endosseous implants: results after 12- 124 months. Clin Oral Implants Res 2001;12:279- 286.
• Geurs NC, Wang IC, Shulman LB, Jeffcoat MK. Retrospective radiographic analysis of sinus graft and implant placement procedures from the Academy Conference on Sinus Grafts. Int J Periodontics Restorative Dent 2001;21:517-523. Consensus
• Simonpieri A, Del Corso M, Sammartino G, Dohan Ehrenfest DM. The relevance of Choukroun's platelet-rich fibrin and metronidazole during complex maxillary rehabilitations using bone allograft. Part I: a new grafting protocol. Implant Dent 2009;18:102-111.
• Simonpieri A, Del Corso M, Sammartino G, Dohan Ehrenfest DM. The relevance of Choukroun's platelet-rich fibrin and metronidazole during complex maxillary rehabilitations using bone allograft. Part II: implant surgery, prosthodontics, and survival. Implant Dent 2009;18:220-229.
• Darby I, Chen ST, Buser D. Ridge preservation techniques for implant therapy. Int J Oral Maxillofac Implants 2009;24 Suppl:260-271.
• M. T. Peck JM, L. Stephen. Alveolar Ridge Preservation Using Leukocyte and Platelet-Rich Fibrin: A Report of a Case 2011.
• Aroca S, Keglevich T, Barbieri B, Gera I, Etienne D. Clinical evaluation of a modified coronally advanced flap alone or in combination with a platelet-rich fibrin membrane for the treatment of adjacent multiple gingival recessions: a 6-month study. J Periodontol 2009;80:244-252. 48. Anilkumar K, Geetha A, Umasudhakar, Ramakrishnan T, Vijayalakshmi R, Pameela E. Platelet-rich-fibrin: A novel root coverage approach. J Indian Soc Periodontol 2009;13:50-54.
• Jankovic S, Aleksic Z, Milinkovic I, Dimitrijevic B. The coronally advanced flap in combination with platelet-rich fibrin (PRF) and enamel matrix derivative in the treatment of gingival recession: a comparative study. Eur J Esthet Dent;5:260-273.
• Del Corso M, Sammartino G, Dohan Ehrenfest DM. Re: "Clinical evaluation of a modified coronally advanced flap alone or in combination with a platelet-rich fibrin membrane for the treatment of adjacent multiple gingival recessions: a 6-month study". J Periodontol 2009;80:1694-1697; author reply 1697-1699.